Explore 2026 CLL frontline choices, from all-oral acalabrutinib–venetoclax to MRD-guided care, plus pipeline advances and ...

The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) ...

Lindsey DeSoto, RD, is a nutrition writer, medical reviewer, and registered dietitian who helps clients improve their diet for health-related reasons. Her writing covers a variety of topics, including ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

The tumor begins before birth. Somewhere in the developing fetus, neural crest cells that should have matured into adrenal tissue or sympathetic ganglia take a wrong turn, and a child is born ...

The phase 2 ASSIST trial showed that atrasentan has an additional antiproteinuric effect -- approximately 25% -- over 12 weeks in patients with earlier-stage IgA nephropathy already receiving ...

Booster or add-on medications can help your antidepressant work better. Learn affordable ways to enhance your treatment.

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration selected enlicitide to receive the Commissioner’s National Priority Voucher (CNPV) in December ...

The pooled overall survival estimate for six phase 3 trials favored PD-1/PD-L1 inhibitor plus platinum-etoposide over platinum-etoposide alone In the treatment of extensive-stage small-cell lung ...

Investigators suggest LDL targets typically reserved for secondary prevention are best in high-risk patients with diabetes.

Final analysis from the phase 2 OVATION 2 trial (NCT03393884) has demonstrated a continued and growing overall survival (OS) advantage with IMNN-001 plus standard-of-care (SOC) neoadjuvant and ...